Cardiovascular disease remains the leading cause of death globally, yet the biological mechanisms through which sex hormones modulate cardiac and vascular risk continue to be incompletely understood — a gap that has direct implications for how clinicians and researchers think about risk stratification across different populations.
Published in the New England Journal of Medicine, this correspondence explores how sex hormones — primarily estrogens, androgens, and progesterone — exert differential effects on cardiovascular physiology. The piece addresses how these hormones interact with lipid metabolism, endothelial function, inflammation, and blood pressure regulation through both genomic and non-genomic signaling pathways. The hormonal milieu appears to influence cardiovascular risk not as a simple binary but along a continuum, with timing, receptor density, and metabolic context all playing modulating roles.
The broader research landscape here is rich and contested. Decades of observational data suggested that premenopausal estrogen exposure conferred cardiovascular protection, a hypothesis that was substantially complicated by the Women's Health Initiative trials, which found that exogenous hormone therapy initiated later in life did not uniformly reproduce those benefits and in some analyses elevated risk. The "timing hypothesis" — that hormonal interventions are cardioprotective when initiated close to menopause onset — has since gained traction but remains incompletely validated in large randomized trials. On the androgen side, testosterone's relationship with cardiovascular outcomes in men has proven similarly nuanced: deficiency correlates with metabolic dysfunction, but supraphysiologic levels may impose independent vascular strain. The publication in NEJM, a top-tier peer-reviewed journal, signals continued clinical relevance of this question. Because this is a correspondence rather than an original trial, its primary value lies in synthesizing mechanistic reasoning rather than generating new population-level evidence. Readers seeking causal estimates should treat this as expert framing, not definitive guidance.